Jiangsu GDK Biotechnology Co Ltd (688670) — Cash Flow Reinvestment Rate
Jiangsu GDK Biotechnology Co Ltd (688670) has a Cash Flow Reinvestment Rate of 2.99x as of December 2023, reinvesting CN¥241.71 Million (capex CN¥54.00 Million plus investments CN¥-187.71 Million) from operating cash flow of CN¥80.90 Million. Explore Jiangsu GDK Biotechnology Co Ltd (688670) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangsu GDK Biotechnology Co Ltd Cash Flow Reinvestment Rate (2020–2023)
Historical reinvestment intensity for Jiangsu GDK Biotechnology Co Ltd across 4 annual periods. Also explore Jiangsu GDK Biotechnology Co Ltd total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Jiangsu GDK Biotechnology Co Ltd (2020–2023)
Year-by-year capital reinvestment analysis for Jiangsu GDK Biotechnology Co Ltd. For live market cap and broader valuation context, see 688670 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 2.99x | CN¥241.71 Million | CN¥80.90 Million | CN¥54.00 Million | ▼ -58.9% |
| 2022 | 7.28x | CN¥280.87 Million | CN¥38.60 Million | CN¥168.18 Million | ▼ -45.3% |
| 2021 | 13.31x | CN¥1.38 Billion | CN¥103.93 Million | CN¥386.39 Million | ▲ +1199.5% |
| 2020 | 1.02x | CN¥112.07 Million | CN¥109.46 Million | CN¥40.81 Million | — |